Consensus Qiagen N.V.

Equities

QGEN

NL0015001WM6

Market Closed - Nyse 04:00:02 2024-05-23 pm EDT 5-day change 1st Jan Change
43.17 USD -0.76% Intraday chart for Qiagen N.V. -6.13% -3.58%

Evolution of the average Target Price on Qiagen N.V.

Price target over the last 5 years

History of analyst recommendation changes

de58ce1459.SfXAx9KjD5dWLVgDnIM3wSxb8X2FEppIZGjz9gFKj_I.Pcant5fFRvITXTJw7bt2kkdpmyKyYe8wVCXKnDIM4Zgau5O-o5s57hMdYA~29207c427080d4daef30c2e7357952d1
QIAGEN NV : Berenberg maintains a Buy rating ZD
QIAGEN NV : Berenberg reaffirms its Buy rating ZD
QIAGEN : A decent start to 2024; guidance unchanged Alphavalue
QIAGEN NV : Deutsche Bank reiterates its Buy rating ZD
QIAGEN NV : Jefferies remains Neutral ZD
QIAGEN NV : UBS remains Neutral ZD
QIAGEN NV : UBS remains Neutral ZD
QIAGEN NV : UBS sticks Neutral ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating ZD
QIAGEN NV : UBS reaffirms its Neutral rating ZD
Morgan Stanley Upgrades Qiagen to Overweight From Equalweight, Adjusts Price Target to $49.48 From $51 MT
QIAGEN NV : Berenberg reiterates its Buy rating ZD
QIAGEN NV : Deutsche Bank remains its Buy rating ZD
QIAGEN NV : JP Morgan reiterates its Buy rating ZD
QIAGEN NV : UBS reiterates its Neutral rating ZD
QIAGEN : In line Q4; routine business prospects remain intact Alphavalue
QIAGEN NV : Gets a Neutral rating from UBS ZD
QIAGEN NV : Berenberg reaffirms its Buy rating ZD
QIAGEN NV : DZ Bank gives a Buy rating ZD
QIAGEN NV : Deutsche Bank reiterates its Buy rating ZD
BofA Securities Raises Price Target on Qiagen to $55 From $52, Maintains Buy Rating MT
QIAGEN NV : Buy rating from Deutsche Bank ZD
QIAGEN NV : Berenberg reiterates its Buy rating ZD
QIAGEN NV : Morgan Stanley keeps its Buy rating ZD
QIAGEN NV : UBS reiterates its Neutral rating ZD
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
43.17 USD
Average target price
50.14 USD
Spread / Average Target
+16.14%
High Price Target
60 USD
Spread / Highest target
+38.99%
Low Price Target
42.5 USD
Spread / Lowest Target
-1.55%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Qiagen N.V.

BERENBERG Odysseas Manesiotis
alphavalue Anas Patel
DEUTSCHE BANK RESEARCH Falko Friedrichs
UBS Dan Leonard
JEFFERIES Peter Welford
Morgan Stanley
DZ BANK Sven Kürten
JPMORGAN Casey Woodring
BofA Securities
Wells Fargo Securities
Goldman Sachs
JPMorgan Chase
Baird
Invest Securities
Citigroup
DEUTSCHE BANK Falko Friedrichs
KEPLER CHEUVREUX Oliver Reinberg
Redburn
NORDLB Thorsten Strauß
WARBURG RESEARCH Ulrich Huwald
INDEPENDENT RESEARCH Tobias Gottschalt
BARCLAYS Jack Meehan
COMMERZBANK Daniel Wendorff
EVERCORE ISI
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings